Target intelligence / Profile preview

GOLM2 pseudogene 1 (GOLM2P1)

Target
GOLM2P1
Molecular classification
Other (pseudogene)
01

Overview

GOLM2 pseudogene 1 (GOLM2P1), also known as CASC4P1, is annotated as a pseudogene and has no evidence of encoding a functional protein[7]. Pseudogenes are stretches of DNA that resemble functional genes but typically lack the ability to produce functional gene products due to disabling mutations, frameshifts, or premature stop codons. GOLM2P1 is not referenced in the scientific literature as a therapeutic target, receptor, transporter, enzyme, or any protein with biological activity. There is no substantiated evidence for a disease association, molecular function, biomarker utility, or interaction with drugs.\nOf note: The related functional gene is GOLM2 (Golgi membrane protein 2; previously known as CASC4), which is involved in membrane trafficking and has been lightly implicated in cancer biology[3][5], but GOLM2P1 refers only to the pseudogene copy and not the functional protein.\n\nSummary of Key Points:\n- GOLM2P1 is a **pseudogene** and not a coding gene or receptor[7].\n- It is **not a therapeutic target**, nor does it have known function, disease associations, or drug interactions.\n- There is **nothing to suggest a biological or pharmacological role** for GOLM2P1 in available datasets.\n- Any search or therapeutic focus should instead consider the actual protein-coding gene **GOLM2 (Golgi membrane protein 2)**[3][5]; however, this is distinct from GOLM2P1.

Other names
CASC4P1

Beyond the preview

Go deeper on GOLM2 pseudogene 1 (GOLM2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GOLM2 pseudogene 1 (GOLM2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call